Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash from Operations (2022 - 2025)

Praxis Precision Medicines has reported Cash from Operations over the past 4 years, most recently at 76325000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 76325000.0 for Q4 2025, down 36.0% from a year ago — trailing twelve months through Dec 2025 was 249068000.0 (down 89.04% YoY), and the annual figure for FY2025 was 249068000.0, down 89.04%.
  • Cash from Operations for Q4 2025 was 76325000.0 at Praxis Precision Medicines, down from 65057000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for PRAX hit a ceiling of 20857000.0 in Q1 2024 and a floor of 76325000.0 in Q4 2025.
  • Median Cash from Operations over the past 4 years was 38882500.0 (2022), compared with a mean of 42312750.0.
  • Biggest five-year swings in Cash from Operations: soared 48.32% in 2023 and later plummeted 154.16% in 2025.
  • Praxis Precision Medicines' Cash from Operations stood at 28806000.0 in 2022, then grew by 17.17% to 23861000.0 in 2023, then plummeted by 135.2% to 56122000.0 in 2024, then plummeted by 36.0% to 76325000.0 in 2025.
  • The last three reported values for Cash from Operations were 76325000.0 (Q4 2025), 65057000.0 (Q3 2025), and 54676000.0 (Q2 2025) per Business Quant data.